I 

108TH CONGRESS 

2D SESSION H. R. 4882

To amend the Controlled Substances Import and Export Act to provide 

authority to the Attorney General to authorize narcotic drugs in schedule 

I, II, III, or IV and nonnarcotic controlled substances in schedule I 

or II to be exported from the United States to a country for subsequent 

export from that country to another country, if certain conditions are 

met. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 21, 2004

Mr. PITTS (for himself, Mr. BROWN of Ohio, Mr. GREENWOOD, Ms. ESHOO, 

Mr. DEAL of Georgia, Mr. GERLACH, Mr. WELDON of Pennsylvania, Mr. 

CANNON, Mr. MATHESON, Mr. HOUGHTON, Mr. BISHOP of Utah, and 

Mr. CUNNINGHAM) introduced the following bill; which was referred to 

the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by 

the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL

To amend the Controlled Substances Import and Export 

Act to provide authority to the Attorney General to authorize narcotic drugs in schedule I, II, III, or IV and 

nonnarcotic controlled substances in schedule I or II 

to be exported from the United States to a country 

for subsequent export from that country to another country, if certain conditions are met.
2

•HR 4882 IH 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Controlled Substances 

5 Export Reform Act of 2004’’. 

6 SEC. 2. REEXPORTATION OF CONTROLLED SUBSTANCES. 

7 Section 1003 of the Controlled Substances Import 

8 and Export Act (21 U.S.C. 953) is amended by adding 

9 at the end the following subsection: 

10 ‘‘(f) Notwithstanding subsections (a)(4) and (c)(3), 

11 the Attorney General may authorize any narcotic drug in 

12 schedule I, II, III, or IV or any nonnarcotic controlled sub13 stance in schedule I or II (which drug or substance is re14 ferred to in this subsection as a ‘covered drug’) to be ex15 ported from the United States to a country for subsequent 

16 export from that country to another country, if each of 

17 the following conditions is met: 

18 ‘‘(1) Both the country to which the covered 

19 drug is exported from the United States (referred to 

20 in this subsection as the ‘first country’) and the 

21 country to which the drug is exported from the first 

22 country (referred to in this section as the ‘second 

23 country’) are parties to the Conventions referred to 

24 in subsections (a)(1)(C) and (e)(3). 
3

•HR 4882 IH 

1 ‘‘(2) The first country and the second country 

2 have each instituted and maintain, in conformity to 

3 such Conventions, a system of controls of imports of 

4 controlled substances which the Attorney General 

5 deems adequate. 

6 ‘‘(3) With respect to the first country, the cov7 ered drug is consigned to a holder of such permits 

8 or licenses as may be required under the laws of 

9 such country, and a permit or license to import the 

10 drug has been issued by the country. 

11 ‘‘(4) With respect to the second country, sub12 stantial evidence is furnished to the Attorney Gen13 eral by the person who will export the covered drug 

14 from the United States that—

15 ‘‘(A) the drug is to be consigned to a hold16 er of such permits or licenses as may be re17 quired under the laws of such country, and a 

18 permit or license to import the drug is to be 

19 issued by the country; 

20 ‘‘(B) there is an actual need for the drug 

21 for medical, scientific, or other legitimate uses 

22 within the country; and 

23 ‘‘(C) the drug will not be exported from 

24 the country. 
4

•HR 4882 IH 

1 ‘‘(5) Within 30 days after the covered drug is 

2 exported from the first country to the second coun3 try, the person who exported the drug from the 

4 United States delivers to the Attorney General docu5 mentation certifying that such export from the first 

6 country has occurred. 

7 ‘‘(6) A permit to export the covered drug from 

8 the United States has been issued by the Attorney 

9 General.’’.

Æ